Inventor
Ann W. Newman
Inventor
Lafayette, IN, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes23%
C07BGeneral methods of organic chemistry23%
PatentTitleYear
11,065,237Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof202110,596,158Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof202010,149,842Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof20189,987,262Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof20189,701,636'Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof'20176,413,969'Gatifloxacin pentahydrate'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002Patents assigned to BRISTOL MYERS SQUIBB CO (1)· patent assignee history
2002–2021Based in Lafayette, IN, US· patent location history
2017–2021Patents assigned to AKEBIA THERAPEUTICS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 5 | 2017–2021 |
| BRISTOL MYERS SQUIBB CO | 1 | 2002 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lafayette, IN, US | 6 | 2002–2021 |